Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate
- PMID: 17257584
- DOI: 10.1016/j.bbrc.2007.01.033
Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate
Abstract
The binding characteristics of two monoclonal antibodies (mAb) to phosphatidylinositol-4-phosphate (PIP) were examined: a murine IgM mAb to PIP; and a human IgG mAb (4E10) that binds both to HIV-1 envelope protein and also to neutral and anionic phospholipids, including PIP. Binding of each mAb to pure PIP was inhibited by Ca(2+) as determined by ELISA. When studied by surface plasmon resonance, liposomes containing PIP could be stripped (i.e., removed) by either Ca(2+) or phosphorylated haptens after binding of the liposomes to the murine anti-PIP antibody attached to a BIAcore chip. In contrast, the binding of liposomal PIP to 4E10 was irreversible and could not be stripped. We therefore conclude that Ca(2+) and phosphate can modulate the initial binding of both types of antibodies to PIP. However, 4E10 binds to liposomal PIP in a two-stage process involving first Ca(2+)-modulated binding to the PIP polar headgroup, followed by irreversible binding to liposomal hydrophobic groups.
Similar articles
-
Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.AIDS. 2009 Oct 23;23(16):2069-77. doi: 10.1097/QAD.0b013e32832faea5. AIDS. 2009. PMID: 19710597
-
Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes.J Drug Target. 2008 Aug;16(7):535-42. doi: 10.1080/10611860802228517. J Drug Target. 2008. PMID: 18686123
-
Lipid A and liposomes containing lipid A as antigens and adjuvants.Vaccine. 2008 Jun 6;26(24):3036-45. doi: 10.1016/j.vaccine.2007.12.002. Epub 2007 Dec 26. Vaccine. 2008. PMID: 18226433
-
Lupus anticoagulant activities of murine monoclonal antibodies to liposomal phosphatidylinositol phosphate.Clin Exp Immunol. 1987 Aug;69(2):403-8. Clin Exp Immunol. 1987. PMID: 2820640 Free PMC article.
-
Use of liposomes containing carbohydrates for production of monoclonal antibodies.Methods Mol Biol. 2002;199:203-18. doi: 10.1385/1-59259-175-2:203. Methods Mol Biol. 2002. PMID: 12094571 Review. No abstract available.
Cited by
-
Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission.Biochim Biophys Acta. 2008 Jul-Aug;1778(7-8):1624-39. doi: 10.1016/j.bbamem.2007.12.018. Epub 2008 Jan 3. Biochim Biophys Acta. 2008. PMID: 18222166 Free PMC article. Review.
-
Reactivity profiles of broadly neutralizing anti-HIV-1 antibodies are distinct from those of pathogenic autoantibodies.AIDS. 2011 Jun 19;25(10):1247-57. doi: 10.1097/QAD.0b013e32834785cf. AIDS. 2011. PMID: 21508803 Free PMC article.
-
Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines.Biochem Biophys Res Commun. 2010 Nov 26;402(4):808-12. doi: 10.1016/j.bbrc.2010.10.124. Epub 2010 Oct 30. Biochem Biophys Res Commun. 2010. PMID: 21040700 Free PMC article.
-
Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens.J Virol. 2008 Jul;82(14):6869-79. doi: 10.1128/JVI.00033-08. Epub 2008 May 14. J Virol. 2008. PMID: 18480433 Free PMC article.
-
The broadly neutralizing anti-human immunodeficiency virus type 1 4E10 monoclonal antibody is better adapted to membrane-bound epitope recognition and blocking than 2F5.J Virol. 2008 Sep;82(18):8986-96. doi: 10.1128/JVI.00846-08. Epub 2008 Jul 2. J Virol. 2008. PMID: 18596094 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous